IDA Ireland has described Ireland as a "key part of sophisticated global supply chains within the biopharmaceutical industry".
It comes after US President Donald Trump vowed to bring US pharmaceutical manufacturing back to America, making specific reference to Ireland.In a statement following Mr Trump's comments, a spokesman for IDA Ireland said that companies that are based in Ireland are at the "cutting edge of developing and manufacturing complex oftentimes life-saving drugs for patients which are exported throughout the world".
Kevin Sammon said: "Ireland has built up a very robust life sciences and biopharmaceutical industry over many years, the quality and depth of which is recognised across the world."
"Ireland's combination of track record, skills availability, manufacturing quality, consistent pro-enterprise policies, high regulatory standards and access to the European Union, is a mix that appeals to many companies."
